Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI-Reference-Cited by-同舟云学术

Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI

Published:2018-07-19 Issue:12 Volume:103 Page:2097-2108
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Nicolson Phillip L.R.,Hughes Craig E.,Watson Stephanie,Nock Sophie H.,Hardy Alexander T.,Watson Callum N.,Montague Samantha J.,Clifford Hayley,Huissoon Aarnoud P.,Malcor Jean-Daniel,Thomas Mark R.,Pollitt Alice Y.,Tomlinson Michael G.,Pratt Guy,Watson Steve P.

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Bruton’s tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments;Advances in Rheumatology;2024-08-21

2. Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted Agents;Cancers;2024-05-24

3. Multi-phased Kinetics and Interaction of Protein Kinase Signaling in Glycoprotein VI-Induced Platelet αIIbβ3 Integrin Activation and Degranulation;Thrombosis and Haemostasis;2024-04-23

4. Bleeding Risk With Antiplatelets and Bruton's Tyrosine Kinase Inhibitors in Patients With Percutaneous Coronary Intervention;Journal of the Society for Cardiovascular Angiography & Interventions;2023-05

5. Differential Regulation of GPVI-Induced Btk and Syk Activation by PKC, PKA and PP2A in Human Platelets;International Journal of Molecular Sciences;2023-04-24